Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Clinical trial NCT05605535 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05605535
Sponsor: CanariaBio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasm Epithelial Ovarian Cancer Fallopian Tube Neoplasms Peritoneal Carcinoma Ovarian Serous Adenocarcinoma

Start date: 2023-02-07
Primary completion: 2026-10-15
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.